Skip to main content
. Author manuscript; available in PMC: 2020 Aug 2.
Published in final edited form as: Clin Cancer Res. 2018 Mar 13;24(12):2820–2827. doi: 10.1158/1078-0432.CCR-17-2940

Figure 5. Clinical cohort. Overall Survival Stage IV CRC Patients. Disease Free Survival Stages II and III CRC Patients. TFAP2E Methylation.

Figure 5.

(A) Overall Survival of patients with stage IV CRC during FU (follow-up), according to TFAP2E methylation status. (B) Disease Free Survival of patients with stage II+III CRC, according to TFAP2E methylation status (C) Disease Free Survival of patients with stage II CRC, according to TFAP2E methylation status (D) Disease Free Survival of patients with stage III CRC, according to TFAP2E methylation status.